Pharmaceutical sciences

Pharmacy Benefit Management Institute® Partners With Medstro® to Launch the PBMI Innovation Challenge

Retrieved on: 
Thursday, July 1, 2021

CRANBURY, N.J., July 1, 2021 /PRNewswire/ --Pharmacy Benefit Management Institute(PBMI) and Medstro are proud to announce the inaugural PBMI Innovation Challenge.

Key Points: 
  • CRANBURY, N.J., July 1, 2021 /PRNewswire/ --Pharmacy Benefit Management Institute(PBMI) and Medstro are proud to announce the inaugural PBMI Innovation Challenge.
  • "We are eager to launch this program," said Mike Hennessy Jr., president and CEO of MJH Life Sciences, parent company of Pharmacy Benefit Management Institute and Medstro.
  • "The PBMI Innovation Challenge offers an excellent opportunity for patients, clinicians, and pharmacy benefit managers to showcase their abilities and collaborate to optimize health care delivery and patient care; we look forward to working together to improve health management solutions."
  • The Pharmacy Benefit Management Institute (PBMI) is the nation's leading provider of research and education about drug cost management to the pharmacy benefit community.

United States Financial Services for CBD Companies Regulatory Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 30, 2021

The "Regulatory Report: Financial Services for CBD Companies in the US" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Regulatory Report: Financial Services for CBD Companies in the US" report has been added to ResearchAndMarkets.com's offering.
  • This report addresses the reasons why the problem persists, what can be done in the current climate, and what might be done to address the problem.
  • However, the problem runs much deeper than cannabis dispensaries and uniquely affects the CBD industry.
  • The Bank Secrecy Act (BSA) of 1970 requires financial institutions to assist federal agencies in detecting and preventing money laundering.

Leading Drug Pricing Experts - Legacy Health Endowment and Powers Law - Collaborate on Series of Issue Papers: Initial Paper Focuses on Intersection of PBMs and the 340B Drug Pricing Program

Retrieved on: 
Tuesday, June 29, 2021

Few Americans are aware, however, that the federal 340B drug pricing program is already providing relief from high drug prices for safety net providers and the communities they serve.

Key Points: 
  • Few Americans are aware, however, that the federal 340B drug pricing program is already providing relief from high drug prices for safety net providers and the communities they serve.
  • Many people also do not know that the 340B program is under attack from both the drug manufacturers selling 340B drugs and the pharmacy benefit managers (PBMs) paying for them.
  • "The 340B program and PBMs are two inextricably linked pieces of the U.S. healthcare system," said Jeffrey Lewis, President, and CEO of Legacy Health Endowment.
  • The firm's drug pricing practice is led by William von Oehsen, one of the architects of the 340B program.

Walmart.com Now Offers OnMi Transdermal Supplement Patches

Retrieved on: 
Monday, June 28, 2021

PALM BEACH, FL, June 28, 2021 (GLOBE NEWSWIRE) -- Walmart.com now offers OnMi patches for wellness, support, and relief.

Key Points: 
  • PALM BEACH, FL, June 28, 2021 (GLOBE NEWSWIRE) -- Walmart.com now offers OnMi patches for wellness, support, and relief.
  • OnMi transdermal patches stand apart from other supplements on the market because it gives you 100 percent vitamins and minerals without any filler ingredients or sugar.
  • For 40 percent of consumers in the United States who have trouble swallowing pills, tablets or capsules, OnMi patches are a solution they will love.
  • OnMi also offers Crave-Less, which helps you say no to cravings, and Hangover, which boosts yourbody's ability to bounce back.

LowerMyRx Has Saved Patients Millions on Medication Purchases

Retrieved on: 
Thursday, June 24, 2021

MOUNT LAUREL, N.J., June 24, 2021 /PRNewswire/ -- LowerMyRx, a nationwide prescription discount program, announced today that their free service has been able to save patients millions of dollars on medication purchases over the past eightyears.

Key Points: 
  • MOUNT LAUREL, N.J., June 24, 2021 /PRNewswire/ -- LowerMyRx, a nationwide prescription discount program, announced today that their free service has been able to save patients millions of dollars on medication purchases over the past eightyears.
  • LowerMyRx helps consumers search and compare discounted medication prices, saving patients up to 80% at thousands of pharmacies nationwide.
  • Whether it be blood pressure medication or cholesterol-lowering medication, patients can search for discounts on LowerMyRx.com and save.
  • Lowering medication costs since 2013, LowerMyRx strives to help as many patients as possible and make medication affordable for all.

OROS Closes $14.5 Million Series A Funding Round

Retrieved on: 
Thursday, June 24, 2021

OROS today announced $14.5 million in a Series A funding round led by Elizabeth Street Ventures and Enlightenment Capital.

Key Points: 
  • OROS today announced $14.5 million in a Series A funding round led by Elizabeth Street Ventures and Enlightenment Capital.
  • Equal parts materials technology company and performance apparel brand, OROS is using first-to-market insulation technology to transform advanced thermal materials into technical fabrics.
  • OROS has made it its mission to evolve the science of staying warm.
  • In addition to the Series A round, OROS is also announcing Rachael Ulmans appointment to the board of directors.

US Patient Perspective of the Corporate Reputation of Pharma in 2020 During the COVID-19 Pandemic - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 24, 2021

The "The Corporate Reputation of Pharma in 2020 during the Covid Pandemic - the US Patient Perspective" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Corporate Reputation of Pharma in 2020 during the Covid Pandemic - the US Patient Perspective" report has been added to ResearchAndMarkets.com's offering.
  • The pharma industry's corporate reputation in the US in 2020: 2020's respondent US patient groups rated the corporate reputation of the pharma industry as a whole far more favourably than in previous years.
  • Only the biotechnology sector outranked the pharma industry for corporate reputation in the US in 2020, according to respondent US patient groups.
  • Pharma was assessed across a wide range of its activities important to patients and patient groups, including a new indicator for 2020 - pharma's effectiveness at tackling Covid.

Hundreds Of Patients Benefit From Access To Promising Treatments For Complex And Rare Disease Using AnovaOS™

Retrieved on: 
Thursday, June 24, 2021

Anova Enterprises, Inc. (Anova), an organization dedicated to accelerating promising treatments to market with its transformative AnovaOS technology platform, continues to see the benefits of improved access to investigational treatment for patients with serious, complex and rare disease.

Key Points: 
  • Anova Enterprises, Inc. (Anova), an organization dedicated to accelerating promising treatments to market with its transformative AnovaOS technology platform, continues to see the benefits of improved access to investigational treatment for patients with serious, complex and rare disease.
  • SSCF uses AnovaOS to manage access to investigational products for oncology patients at partner oncology practices in Washington state.
  • Biopharmaceutical companies face increased pressure to make investigational products available to patients who have serious and/or life-threatening disease.
  • With the support of AnovaOS the opportunity for physicians and their patients to access promising investigational treatments has dramatically improved.

Trulieve Expands Access to Medical Cannabis in Central Florida with New Winter Park Location

Retrieved on: 
Wednesday, June 23, 2021

The latest dispensary, located in Winter Park, supports Trulieve's goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on.

Key Points: 
  • The latest dispensary, located in Winter Park, supports Trulieve's goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on.
  • The dispensary expands access throughout Central Florida, joining four locations throughout nearby Orlando.
  • Trulieve also offers home delivery statewide for patients and convenient in-store pickup at each of its 85 dispensaries in Florida.
  • Trulieve is primarily a vertically integrated "seed-to-sale" company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida.

Patented Medicine Prices Review Board Risks Harming the Health of Canadians by Reducing Access to New Medicines

Retrieved on: 
Wednesday, June 23, 2021

IMC firmly maintains that industry is prepared to consult and collaborate with governments with a view to protecting the health of Canadians.

Key Points: 
  • IMC firmly maintains that industry is prepared to consult and collaborate with governments with a view to protecting the health of Canadians.
  • Regulatory amendments to the Patented Medicine Prices Review Board (PMPRB), Canada's drug pricing ceiling regulator are set to be implemented on July 1.
  • These severe changes will impede R&D investment in Canada's biopharmaceutical sector and reduce access to new medicines for Canadians.
  • Our industry stands ready to collaborate with governments on changes to the PMPRB that will be less damaging to Canada's domestic life sciences capacity and timely access to medicines and vaccines for all Canadians.